Page last updated: 2024-11-04

temozolomide and Retroperitoneal Neoplasms

temozolomide has been researched along with Retroperitoneal Neoplasms in 2 studies

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research Excerpts

ExcerptRelevanceReference
"Ten percent of paragangliomas are malignant and one-third occurs in a genetic background."5.38A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. ( Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T, 2012)
"Ten percent of paragangliomas are malignant and one-third occurs in a genetic background."1.38A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine. ( Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maroto, P1
Huddart, R1
Garcia del Muro, X1
Horwich, A1
Paz Ares, L1
Aparicio, J1
Germa-Lluch, JR1
Nozières, C1
Walter, T1
Joly, MO1
Giraud, S1
Scoazec, JY1
Borson-Chazot, F1
Simon, C1
Riou, JP1
Lombard-Bohas, C1

Trials

1 trial available for temozolomide and Retroperitoneal Neoplasms

ArticleYear
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors.
    Oncology, 2011, Volume: 80, Issue:3-4

    Topics: Adult; Antineoplastic Agents; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Humans; Male; Media

2011

Other Studies

1 other study available for temozolomide and Retroperitoneal Neoplasms

ArticleYear
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.
    European journal of endocrinology, 2012, Volume: 166, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Dacarbazine;

2012